Clinical Trials Browser

Phase 1 × Withdrawn × Fondaparinux × Clear all

NCT00659399 2015-03-18

Feasibility Study of Short Term Fondaparinux (Arixtra) in Chemotherapy-Pretreated Ovarian Carcinoma Patients at High Risk of Progression

Phase 1 Withdrawn

Ovarian Neoplasms